Analgesics Market by Drug Type (Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, Salicylates), Type (Non-Opioids, Opioids), Route of Administration, Distribution - Global Forecast 2024-2030
Description
Analgesics Market by Drug Type (Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, Salicylates), Type (Non-Opioids, Opioids), Route of Administration, Distribution - Global Forecast 2024-2030
The Analgesics Market size was estimated at USD 21.85 billion in 2023 and expected to reach USD 23.75 billion in 2024, at a CAGR 8.79% to reach USD 39.42 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Analgesics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Analgesics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Analgesics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Assertio Therapeutics, Inc., Bausch Health Companies Inc., Baxter International Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Endo Pharmaceuticals Inc., Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., Purdue Pharmaceuticals L.P., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries, Inc., and Teva Pharmaceutical Industries Ltd..
Market Segmentation & Coverage
This research report categorizes the Analgesics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Drug Type
Acetaminophen
Non-Opioids
Intravenous
Hospital Pharmacies
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Analgesics Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Analgesics Market?
- What are the technology trends and regulatory frameworks in the Analgesics Market?
- What is the market share of the leading vendors in the Analgesics Market?
- Which modes and strategic moves are suitable for entering the Analgesics Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
195 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Analgesics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising incidences of cardiovascular disease (CVD), cancer, & arthritis
- 5.1.1.2. Prevalence of regular analgesic treatment has increased among community-dwelling older person
- 5.1.1.3. Cost-effectiveness of over-the-counter analgesic medications
- 5.1.2. Restraints
- 5.1.2.1. Uncontrolled prescriptions of opioids and drug abuse
- 5.1.3. Opportunities
- 5.1.3.1. Increasing investments in R&D by the public & private sectors
- 5.1.3.2. Surge in popularity of personalized medicine
- 5.1.4. Challenges
- 5.1.4.1. Limited availability and affordability of high efficacy drugs, including opioid analgesics
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Analgesics Market, by Drug Type
- 6.1. Introduction
- 6.2. Acetaminophen
- 6.3. Nonsteroidal Anti-Inflammatory Drugs
- 6.4. Salicylates
- 7. Analgesics Market, by Type
- 7.1. Introduction
- 7.2. Non-Opioids
- 7.3. Opioids
- 8. Analgesics Market, by Route of Administration
- 8.1. Introduction
- 8.2. Intravenous
- 8.3. Oral
- 8.4. Rectal
- 8.5. Topical
- 8.6. Transdermal
- 9. Analgesics Market, by Distribution
- 9.1. Introduction
- 9.2. Hospital Pharmacies
- 9.3. Online Pharmacies
- 9.4. Retail Pharmacies
- 10. Americas Analgesics Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Analgesics Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Analgesics Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. AbbVie Inc.
- 14.1.2. Assertio Therapeutics, Inc.
- 14.1.3. Bausch Health Companies Inc.
- 14.1.4. Baxter International Inc.
- 14.1.5. Bayer AG
- 14.1.6. Boehringer Ingelheim International GmbH
- 14.1.7. Bristol-Myers Squibb Company
- 14.1.8. Eli Lilly and Company
- 14.1.9. Endo Pharmaceuticals Inc.
- 14.1.10. Glaxosmithkline PLC
- 14.1.11. Johnson & Johnson Services, Inc.
- 14.1.12. Novartis AG
- 14.1.13. Pfizer Inc.
- 14.1.14. Purdue Pharmaceuticals L.P.
- 14.1.15. Reckitt Benckiser Group PLC
- 14.1.16. Sun Pharmaceutical Industries, Inc.
- 14.1.17. Teva Pharmaceutical Industries Ltd.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. ANALGESICS MARKET RESEARCH PROCESS
- FIGURE 2. ANALGESICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. ANALGESICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ANALGESICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ANALGESICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ANALGESICS MARKET DYNAMICS
- FIGURE 7. ANALGESICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
- FIGURE 8. ANALGESICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ANALGESICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 10. ANALGESICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
- FIGURE 12. ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
- FIGURE 14. ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES ANALGESICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES ANALGESICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. ANALGESICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. ANALGESICS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
